Genetix Biotherapeutics Inc. Company Profile
✉ Email this page to a colleague
Biologic Drugs for Genetix Biotherapeutics Inc.
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Patent No. | Estimated Patent Expiration | Source |
|---|---|---|---|---|---|---|---|
| Genetix Biotherapeutics Inc. | ZYNTEGLO | betibeglogene autotemcel | For Injection | 125717 | 7,541,179 | 2022-07-01 | DrugPatentWatch analysis and company disclosures |
| Genetix Biotherapeutics Inc. | ZYNTEGLO | betibeglogene autotemcel | For Injection | 125717 | 8,058,061 | 2029-04-30 | DrugPatentWatch analysis and company disclosures |
| Genetix Biotherapeutics Inc. | SKYSONA | elivaldogene autotemcel | Injection | 125755 | 10,563,172 | 2037-03-14 | DrugPatentWatch analysis and company disclosures |
| Genetix Biotherapeutics Inc. | SKYSONA | elivaldogene autotemcel | Injection | 125755 | 10,995,346 | 2037-07-14 | DrugPatentWatch analysis and company disclosures |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Patent No. | >Estimated Patent Expiration | >Source |
